#361 Advanced Lipidology
The Curbsiders Internal Medicine Podcast
00:00
Is Lipritual a Reduced in Phase Two Trials?
The agent that's the farthest along in trials it's already in phase three cardiovascular outcome trials is pila karsten. The drugs seem to you know lower the target lipritual a and in phase one phase two trials seem to be safe but we really need the larger outcome trials before there would be any FDA indication or before they would be available for patients.
Transcript
Play full episode
